Search

Author/Creator Homenda, Wojciech

1. A 5-year follow-up to evaluate the efficacy and safety of ofatumumab added to fludarabine and cyclophosphamide in patients with relapsed chronic lymphocytic leukemia: final analysis of the COMPLEMENT 2 trial. Issue 7 (6th June 2020)

Authors:
Grosicki, Sebastian; Lech-Maranda, Ewa; Govind Babu, Kanakasetty; Rybka, Justyna; Litvinskaya, Elena; Loscertales, Javier; Kriachok, Iryna; Kłoczko, Janusz; Rekhtman, Grygoriy; Homenda, Wojciech; Blonski, Jerzy; Stefanelli, Tommaso; Vincent, Ghislaine; Banerjee, Hiya; Robak, Tadeusz
Journal:
Leukemia & lymphoma
Issue:
Volume 61:Issue 7(2020)
Page Start:
1748
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase 2, multicenter study investigating ofatumumab and bendamustine combination in patients with untreated or relapsed CLL. Issue 9 (3rd July 2016)

Authors:
Flinn, Ian W.; Panayiotidis, Panayiotis; Afanasyev, Boris; Janssens, Ann; Grosicki, Sebastian; Homenda, Wojciech; Smolej, Lukas; Kuliczkowski, Kazimierz; Doubek, Michael; Domnikova, Natalia; West, Sarah L.; Chang, Chai‐Ni; Barker, Alison M.; Gupta, Ira V.; Wright, Oliver J.; Offner, Fritz
Journal:
American journal of hematology
Issue:
Volume 91:Issue 9(2016:Sep.)
Page Start:
900
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Are myelodysplastic syndromes underdiagnosed in Poland? A report by the Polish Adult Leukaemia Group. (1st November 2016)

Authors:
Drozd‐Sokołowska, Joanna E.; Mądry, Krzysztof; Waszczuk‐Gajda, Anna; Żółtak, Tomasz; Sikorska, Anna; Mital, Andrzej; Wajs, Jarosław; Semeńczuk, Grażyna; Szmigielska‐Kapłon, Anna; Szczepańska, Magdalena; Wasilewska, Ewa; Szwedyk, Paweł; Hołojda, Jadwiga; Wątek, Marzena; Stella‐Hołowiecka, Beata; S...
Journal:
European journal of haematology
Issue:
Volume 98:Number 2(2017:Feb.)
Page Start:
154
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trials. Issue 7 (15th May 2018)

Authors:
Bussel, James; Arnold, Donald M.; Grossbard, Elliot; Mayer, Jiří; Treliński, Jacek; Homenda, Wojciech; Hellmann, Andrzej; Windyga, Jerzy; Sivcheva, Liliya; Khalafallah, Alhossain A.; Zaja, Francesco; Cooper, Nichola; Markovtsov, Vadim; Zayed, Hany; Duliege, Anne‐Marie
Journal:
American journal of hematology
Issue:
Volume 93:Issue 7(2018:Jul.)
Page Start:
921
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Health-related quality of life and patient-reported outcomes of ofatumumab plus fludarabine and cyclophosphamide versus fludarabine and cyclophosphamide in the COMPLEMENT 2 trial of patients with relapsed CLL. Issue 7 (3rd July 2017)

Authors:
Robak, Tadeusz; Warzocha, Krzysztof; Govind Babu, K.; Kulyaba, Yaroslav; Kuliczkowski, Kazimierz; Abdulkadyrov, Kudrat; Loscertales, Javier; Kryachok, Iryna; Kłoczko, Janusz; Rekhtman, Grygoriy; Homenda, Wojciech; Błoński, Jerzy Z.; McKeown, Astrid; Chang, Chai-Ni; Bal, Vasudha; Lisby, Steen; Gup...
Journal:
Leukemia & lymphoma
Issue:
Volume 58:Issue 7(2017)
Page Start:
1598
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Ofatumumab plus fludarabine and cyclophosphamide in relapsed chronic lymphocytic leukemia: results from the COMPLEMENT 2 trial. Issue 5 (4th May 2017)

Authors:
Robak, Tadeusz; Warzocha, Krzysztof; Govind Babu, K.; Kulyaba, Yaroslav; Kuliczkowski, Kazimierz; Abdulkadyrov, Kudrat; Loscertales, Javier; Kryachok, Iryna; Kłoczko, Janusz; Rekhtman, Grygoriy; Homenda, Wojciech; Błoński, Jerzy Z.; McKeown, Astrid; Gorczyca, Michele M.; Carey, Jodi L.; Chang, Ch...
Journal:
Leukemia & lymphoma
Issue:
Volume 58:Issue 5(2017)
Page Start:
1084
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗